1038MO Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
Authors:
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S870
Abstract
No abstract availableFunding Information
- AstraZeneca
- Roche